Concepedia

J O’Byrne

JO

6

Publications

671

Citations

6

H-Index

1996

Active since

Affiliations

Orange Coast Memorial Medical Center(Current)

Amgen (United States)

Campbell Clinic

University of California, Los Angeles

Hematology Oncology Associates

J O’Byrne is an author at Orange Coast Memorial Medical Center specializing in nuclear medicine, radiation oncology, and cancer therapeutics.

Top concepts

Publications per year

1996–2002

6

Publications

6

Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer.

Russell L. Basser, John E.J. Rasko, Kerrie Clarke et al. · PubMed · 1997 · 201 citations

Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy

John A. Glaspy, J. Jadeja, Glen R. Justice et al. · British Journal of Cancer · 2002 · 170 citations · Full text

Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation

Cindy J. O’Malley, RL Basser, KM McGrath et al. · Blood · 1996 · 137 citations · Full text

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy

John A. Glaspy, J. Jadeja, Glen R. Justice et al. · British Journal of Cancer · 2001 · 81 citations · Full text

Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG‐rHuMGDF

John E.J. Rasko, Russell L. Basser, Jan Boyd et al. · British Journal of Haematology · 1997 · 64 citations · Full text

Rows per page

1–5 of 6